labetalol and thromboxane a2

labetalol has been researched along with thromboxane a2 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirose, K; Okuda, C; Sakio, H1
Calder, AA; Forbes, CD; Greer, IA; McLaren, M; Walker, JJ2
Viinikka, L; Ylikorkala, O1
Jouppila, P; Kirkinen, P; Koivula, A; Ylikorkala, O1
Forman, A; Gregersen, H; Petersen, OB; Skajaa, K; Svane, D1
Semczuk, M; SkoczyƄski, M1

Other Studies

7 other study(ies) available for labetalol and thromboxane a2

ArticleYear
[The participation of the sympathetic nervous system in thromboxane A2 release induced by limb ischemia].
    Masui. The Japanese journal of anesthesiology, 1989, Volume: 38, Issue:2

    Topics: Animals; Bupivacaine; Dogs; Ischemia; Labetalol; Leg; Sympathetic Nervous System; Thromboxane A2; Thromboxane B2

1989
Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists.
    Prostaglandins, leukotrienes, and medicine, 1985, Volume: 19, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Epoprostenol; Humans; Labetalol; Pindolol; Propranolol; Thromboxane A2; Thromboxane B2

1985
A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
    Thrombosis and haemostasis, 1985, Aug-30, Volume: 54, Issue:2

    Topics: Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Labetalol; Pindolol; Platelet Aggregation; Prazosin; Propranolol; Thromboxane A2; Thromboxane B2

1985
Beta blockers inhibit fetal thromboxane A2 production in vitro.
    Biology of the neonate, 1988, Volume: 54, Issue:3

    Topics: Adrenergic beta-Antagonists; Atenolol; Blood Platelets; Female; Fetal Blood; Humans; Infant, Newborn; Kinetics; Labetalol; Metoprolol; Pregnancy; Propranolol; Thromboxane A2

1988
Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in pre-eclampsia.
    British journal of obstetrics and gynaecology, 1986, Volume: 93, Issue:6

    Topics: Blood Pressure; Epoprostenol; Female; Fetus; Heart Rate; Hemodynamics; Humans; Labetalol; Placenta; Pre-Eclampsia; Pregnancy; Regional Blood Flow; Thromboxane A2

1986
The effects of dihydralazine, labetalol and magnesium sulphate on the isolated, perfused human placental cotyledon.
    British journal of obstetrics and gynaecology, 1994, Volume: 101, Issue:10

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Dihydralazine; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Labetalol; Magnesium Sulfate; Placenta; Pregnancy; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Vasoconstrictor Agents; Vasodilation

1994
[Influence of labetalol on the resistance of human fetoplacental vessels in perfusion in vitro].
    Ginekologia polska, 2002, Volume: 73, Issue:9

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Dose-Response Relationship, Drug; Female; Fetus; Humans; In Vitro Techniques; Labetalol; Placenta; Placental Circulation; Pregnancy; Thromboxane A2; Vascular Resistance; Vasoconstrictor Agents

2002